drug

bexagliflozin

Marketedupdated 2mo ago

by TheracosBio LLC

Approved

community read0 votes

indications

investigational

Type 2 Diabetes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Jan 20, 2028

~1.5 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

May 14, 2032compositionUS 8987323
Jul 3, 2031method-of-use (U-2214)US 105330325.0y
Jun 13, 2031compositionUS 109819424.9y
Jan 30, 2029compositionUS 78384992.6y
Aug 22, 2028method-of-use (U-2214)US 81060212.1y
Aug 22, 2028compositionUS 88026372.1y

FDA exclusivities (1)

Jan 20, 2028NCENew Chemical Entity (5y)1.5y

Data sources

ClinicalTrials.gov

last refreshed 36m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?